This trial looks at how hot flashes affect women's risk for cardiovascular disease.
- Hot Flashes
- Vasomotor Instability
2 Primary · 0 Secondary · Reporting Duration: Continuous measurement of vascular conductance during infusion of each drug- 3min at baseline and at each drug dose (~60min total of continuous forearm vascular conductance measurements)
0 Treatment Group
120 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Who is running the clinical trial?
Age 40 - 60 · Female Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are elderly participants sought after in this research endeavor?
"This research project is only open to patients between the ages of 45-55. However, there are 8 trials for minors and 55 studies available for those over 65 years old." - Anonymous Online Contributor
To what extent is this clinical trial being populated by participants?
"Affirmative. Information on clinicaltrials.gov seems to indicate that this medical experiment is currently enrolling patients; the trial was first posted on February 24th 2022 and most recently edited on March 14th 2022. The research team requires 120 individuals from 1 site for their study." - Anonymous Online Contributor
Are there any still vacancies in this clinical investigation?
"As per clinicaltrials.gov, this ongoing research is actively recruiting participants from the time of its initial posting on February 24th 2022 to its latest revision on March 14th 2022." - Anonymous Online Contributor
Could I be considered a candidate for the clinical experiment?
"This clinical trial is enrolling 120 adults aged 45-55 experiencing hot flashes. To qualify, applicants must have at least one ovary and cannot be smokers, obese or taking any drugs that might affect cardiovascular function. In addition, they need to be free from any existing cardiovascular conditions" - Anonymous Online Contributor
Have there been previous experiments involving this particular therapeutic approach?
"Presently, 29 investigations of this particular treatment are underway. 5 of these ongoing clinical trials have advanced to Phase 3. The primary research centres for most of the studies can be found in Salt Lake City, Utah though there remain 50 locations running relevant experiments." - Anonymous Online Contributor
What is the usual indication for this therapeutic regimen?
"This therapeutic approach is effective at managing hypotension, preventing preterm labour, and alleviating the symptoms of chronic obstructive airway disease." - Anonymous Online Contributor